In the early stages of epithelial ovarian cancer, CA125 levels are elevated in up to 50% of patients, the marker being specific to advanced stages of the disease, with elevated levels in about 85% of patients [46]. The gene discussed is MUC16; the disease is ovarian carcinoma.